Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Device Detects Malaria in Simple Blood Test

By LabMedica International staff writers
Posted on 18 May 2011
A diagnostic screening device, which separates malaria-infected red blood cells from uninfected red blood cells by way of magnetic levitation has been developed. More...


The prototype system requires less than a drop of finger-prick blood and a small volume of erythrocyte isotonic buffer containing paramagnetic ions and is lightweight, disposable, and inexpensive to manufacture.

Scientists at the Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) used the principles of magnetic levitation and cell phone technology to create an inexpensive, portable device to diagnose malaria quickly and accurately outside of the routine laboratory setting. The device uses a set of permanent magnets immobilized in a plastic structure surrounding a glass or plastic capillary containing the blood. Results are visualized, recorded and stored using a standard camera phone and no additional imaging equipment or staining reagents are required.

Ionita Ghiran, MD, an investigator at BIDMC and an assistant professor of medicine at Harvard Medical School (Boston, MA, USA) has been awarded a $100,000 grant from the Bill & Melinda Gates Foundation (Seattle WA, USA), for the development of the device. Professor Ghiran said, "The lack of suitable methods of malaria diagnosis makes presumptive treatment often the only available option for local health service providers. This method helps fill the need for malarial diagnostic technologies capable of promptly and reliably ascertaining true malarial infections in the field. We hope that this will help prevent the over diagnosis of malaria and subsequent drug resistance."

An estimated 200 to 500 million cases of malaria occur each year with 50% to 90% of these in Africa. Malaria causes nearly one million deaths per year throughout developing countries, 85% of whom are children under the age of five, and parasites are becoming increasingly resistant to antimalarial drugs, in part due to misdiagnosis.

Related Links:
Beth Israel Deaconess Medical Center
Harvard Medical School
Bill & Melinda Gates Foundation




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.